Correction to Moderna Shares and mRNA Cancer Vaccine Article -- WSJ
Dow Jones2026/08/19 20:48
Merck's blockbuster drug is named Keytruda. "Moderna Shares More Than Double on Success of mRNA Cancer Vaccine," at 6:45 a.m. ET , incorrectly called it Ketruda, in one instance.
(END) Dow Jones Newswires
August 19, 2026 16:48 ET (20:48 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.